FI915469A0 - Foerfarande foer framstaellning av nya erytromycinderivat. - Google Patents

Foerfarande foer framstaellning av nya erytromycinderivat.

Info

Publication number
FI915469A0
FI915469A0 FI915469A FI915469A FI915469A0 FI 915469 A0 FI915469 A0 FI 915469A0 FI 915469 A FI915469 A FI 915469A FI 915469 A FI915469 A FI 915469A FI 915469 A0 FI915469 A0 FI 915469A0
Authority
FI
Finland
Prior art keywords
image
erytromycinderivat
nya
forms
foerfarande foer
Prior art date
Application number
FI915469A
Other languages
English (en)
Other versions
FI102281B1 (fi
FI102281B (fi
FI915469A (fi
Inventor
Constantin Agouridas
Yanniok Benedetti
Jean-Francois Chantot
Alexis Denis
Claude Fromentin
Martret Odile Le
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9014499A external-priority patent/FR2669337B1/fr
Priority claimed from FR9106333A external-priority patent/FR2677025B1/fr
Priority claimed from FR9110728A external-priority patent/FR2680790B1/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI915469A0 publication Critical patent/FI915469A0/fi
Publication of FI915469A publication Critical patent/FI915469A/fi
Application granted granted Critical
Publication of FI102281B1 publication Critical patent/FI102281B1/fi
Publication of FI102281B publication Critical patent/FI102281B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
FI915469A 1990-11-21 1991-11-20 Menetelmä uusien erytromysiinijohdannaisten valmistamiseksi FI102281B (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9014499A FR2669337B1 (fr) 1990-11-21 1990-11-21 Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
FR9106333A FR2677025B1 (fr) 1991-05-27 1991-05-27 Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
FR9110728A FR2680790B1 (fr) 1991-08-29 1991-08-29 Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.

Publications (4)

Publication Number Publication Date
FI915469A0 true FI915469A0 (fi) 1991-11-20
FI915469A FI915469A (fi) 1992-05-22
FI102281B1 FI102281B1 (fi) 1998-11-13
FI102281B FI102281B (fi) 1998-11-13

Family

ID=27252354

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915469A FI102281B (fi) 1990-11-21 1991-11-20 Menetelmä uusien erytromysiinijohdannaisten valmistamiseksi

Country Status (26)

Country Link
US (3) US5444051A (fi)
EP (1) EP0487411B1 (fi)
JP (1) JP3130097B2 (fi)
KR (1) KR100189597B1 (fi)
CN (1) CN1033974C (fi)
AT (1) ATE133683T1 (fi)
AU (1) AU640290B2 (fi)
BR (1) BR9105062A (fi)
CA (1) CA2055912C (fi)
CZ (1) CZ290651B6 (fi)
DE (1) DE69116815T2 (fi)
DK (1) DK0487411T3 (fi)
ES (1) ES2082952T3 (fi)
FI (1) FI102281B (fi)
GR (1) GR3018848T3 (fi)
HU (1) HU218787B (fi)
IE (1) IE74713B1 (fi)
IL (3) IL114589A (fi)
MA (1) MA22344A1 (fi)
MX (1) MX9102159A (fi)
NZ (1) NZ240684A (fi)
OA (1) OA09523A (fi)
PL (2) PL167448B1 (fi)
PT (1) PT99569B (fi)
RU (1) RU2100367C1 (fi)
SK (1) SK281550B6 (fi)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
ATE135707T1 (de) * 1992-04-22 1996-04-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolid a derivate
FR2707088B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
KR960700258A (ko) * 1993-01-26 1996-01-19 우에하라 아키라 5-0-데소사미닐에리쓰로노라이드 유도체
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2713226B1 (fr) * 1993-12-03 1996-01-05 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
AU714176B2 (en) * 1995-11-08 1999-12-23 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
USRE38520E1 (en) * 1996-02-28 2004-05-18 Aventis Pharma S.A. Erythromycin derivatives, method for preparing same, and use thereof as drugs
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
IL126624A0 (en) * 1996-05-07 1999-08-17 Abbott Lab 3-descladinose-2, 3-anhydroerythromycin derivatives
AU2340797A (en) * 1996-05-07 1997-11-26 Abbott Laboratories 6-o-substituted erythromycins and method for making them
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
KR100523679B1 (ko) * 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-ｏ-치환된 케톨라이드
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
FR2754821B1 (fr) * 1996-10-23 2003-04-04 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6421398A (en) * 1997-03-24 1998-10-20 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
EA199901016A1 (ru) * 1997-06-11 2000-06-26 Пфайзер Продактс Инк. 9-оксим-производные эритромицина
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
IL134608A0 (en) * 1997-09-30 2001-04-30 Abbott Lab 3'-n- modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
WO1999021868A1 (fr) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
CO4990960A1 (es) * 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
AU1504899A (en) * 1997-12-11 1999-06-28 Hokuriku Seiyaku Co. Ltd Erythromycin derivatives
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US5955440A (en) * 1998-03-27 1999-09-21 Abbott Laboratories Macrolide LHRH antagonists
US5972898A (en) * 1998-03-27 1999-10-26 Abbott Laboratories 3',3-N-bis-substituted macrolide LHRH antagonists
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
US6020521A (en) * 1998-08-26 2000-02-01 Abbott Laboratories Macrolide LHRH antagonists
US6387885B1 (en) * 1998-08-26 2002-05-14 Abbott Laboratories 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
ATE298761T1 (de) 1998-09-22 2005-07-15 Pfizer Prod Inc Carbamat- und carbazatketolidantibiotika
FR2784682B1 (fr) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
USRE39743E1 (en) * 1998-10-15 2007-07-24 Aventis Pharma S.A. 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
AU5995299A (en) * 1998-11-03 2000-05-22 Pfizer Products Inc. Novel macrolide antibiotics
ES2273964T3 (es) 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
ID30233A (id) 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
KR100390159B1 (ko) * 1999-03-09 2003-07-04 (주)니드켐 불소를 함유한 산업폐수 처리제 및 처리방법
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
ATE340183T1 (de) 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) * 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
WO2000062783A2 (en) 1999-04-16 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
HRP990116B1 (en) * 1999-04-20 2007-10-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. NOVEL 8a AND 9a- 15-MEMBERED LACTAMES
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
WO2000075156A1 (en) * 1999-06-07 2000-12-14 Abbott Laboratories 6-o-carbamate ketolide derivatives
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
CA2398848C (en) * 2000-02-24 2007-09-25 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2001261694A (ja) * 2000-03-06 2001-09-26 Pfizer Prod Inc ケトライド抗生物質
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
US20020132782A1 (en) * 2001-01-18 2002-09-19 Zhenkun Ma 9-amino erythromycin derivatives with antibacterial activity
JP2005503416A (ja) 2001-09-17 2005-02-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ６−ｏ−カルバメート−１１，１２−ラクト−ケトライド抗菌剤
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
BR0214748A (pt) 2001-12-05 2004-11-23 Ortho Mcneil Pharm Inc Derivados 6-oacil-cetolidas de eritromicina, úteis como antibacterianos
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
WO2005070918A1 (en) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
CN1659178A (zh) * 2002-05-13 2005-08-24 英安塔制药有限公司 6、11二环红霉素衍生物
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
AU2003234650A1 (en) 2002-05-31 2003-12-19 Janssen Pharmaceutica N.V. 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents
US6812216B2 (en) 2002-06-25 2004-11-02 Enanta Pharmaceuticals, Inc. 11-C-substituted derivatives of clarithromycin
US6750204B2 (en) * 2002-06-25 2004-06-15 Enanta Pharmaceuticals, Inc. 11-C-substituted ketolides
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005028493A1 (en) * 2003-09-12 2005-03-31 Chiron Corporation Antimicrobial derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
AU2003263482A1 (en) * 2003-09-25 2005-04-14 Ranbaxy Laboratories Limited 3'-n-substituted-3-o-substituted erythronolide a derivatives
US20070149463A1 (en) * 2003-10-30 2007-06-28 Oyelere Adegboyega K Bifunctional macrolide heterocyclic compounds and methods of making and using the same
EP1699808A1 (en) * 2003-11-18 2006-09-13 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
AU2003304705A1 (en) * 2003-12-24 2005-08-03 Enanta Pharmaceuticals, Inc. 11-csubsituted erythromycin derivatives
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
JP4737495B2 (ja) * 2004-01-14 2011-08-03 塩野義製薬株式会社 エリスロマイシン誘導体
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
AU2005238313A1 (en) * 2004-04-28 2005-11-10 Alembic Limited Process for the preparation of telithromycin
US20080207536A1 (en) * 2004-07-28 2008-08-28 Ranbaxy Laboratories Limited Antibacterial Agents
ES2317527T3 (es) * 2005-01-13 2009-04-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7582611B2 (en) 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
WO2007012464A1 (en) * 2005-07-26 2007-02-01 Merckle Gmbh Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
BRPI0619556A2 (pt) * 2005-12-08 2011-10-04 Pfizer processo para desmetilação de grupo 3' -dimetil amino de compostos eritromicina
WO2008068593A2 (en) * 2006-12-05 2008-06-12 Pfizer Inc. Motilide polymorphs
JP2010535776A (ja) * 2007-08-10 2010-11-25 ワイズセラピューティックス株式会社 ロキシスロマイシン又はその誘導体の投与による免疫応答の調節
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
CN101855219B (zh) * 2007-09-17 2014-06-25 英安塔制药有限公司 6，11-桥联的联芳大环内酯类
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
EP2214484A4 (en) * 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
KR101026715B1 (ko) * 2008-04-17 2011-04-14 한수케미칼 주식회사 불소이온 및 시안착화합물과 유리시안 제거제 및 이를이용한 폐수 처리방법
TW200946109A (en) 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
US8796232B2 (en) * 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CN103080122A (zh) 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
CN103130852B (zh) * 2011-11-25 2016-03-16 上海医药工业研究院 一种红霉素a衍生物、其制备方法、中间体及应用
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN106457160B (zh) 2014-05-14 2019-10-08 陶氏环球技术有限责任公司 用亚硝酸后处理的复合聚酰胺膜

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU35363B (en) * 1974-01-14 1980-12-31 Pliva Zagreb Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives
PL136968B1 (en) * 1983-02-10 1986-04-30 Tarchominskie Zaklad Farma Process for preparing cyclic 11,12-carbonate of erythromycin a
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
EP0260938B1 (en) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
PT86800B (pt) * 1987-02-24 1992-05-29 Beecham Group Plc Processo para a preparacao de derivados de eritromicina
US4857641A (en) * 1987-08-14 1989-08-15 Pfizer Inc. C.12 modified erythromycin A derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin

Also Published As

Publication number Publication date
IE914029A1 (en) 1992-06-03
PT99569A (pt) 1992-10-30
CN1065069A (zh) 1992-10-07
AU8798691A (en) 1992-05-28
CN1033974C (zh) 1997-02-05
RU2100367C1 (ru) 1997-12-27
CA2055912A1 (fr) 1992-05-21
HU218787B (hu) 2000-12-28
OA09523A (fr) 1992-11-15
MX9102159A (es) 1992-07-08
FI102281B1 (fi) 1998-11-13
KR100189597B1 (ko) 1999-06-01
CZ290651B6 (cs) 2002-09-11
US5444051A (en) 1995-08-22
EP0487411B1 (fr) 1996-01-31
BR9105062A (pt) 1992-06-23
SK281550B6 (sk) 2001-04-09
MA22344A1 (fr) 1992-07-01
IE74713B1 (en) 1997-07-30
EP0487411A1 (fr) 1992-05-27
KR920009840A (ko) 1992-06-25
DK0487411T3 (da) 1996-04-15
PL169422B1 (pl) 1996-07-31
ES2082952T3 (es) 1996-04-01
CS350891A3 (en) 1992-06-17
CA2055912C (fr) 2002-03-19
IL99995A (en) 1997-11-20
AU640290B2 (en) 1993-08-19
HUT61564A (en) 1993-01-28
JPH04290893A (ja) 1992-10-15
HU913622D0 (en) 1992-02-28
PL292455A1 (en) 1992-08-10
FI102281B (fi) 1998-11-13
IL99995A0 (en) 1992-08-18
NZ240684A (en) 1994-08-26
FI915469A (fi) 1992-05-22
GR3018848T3 (en) 1996-05-31
PT99569B (pt) 1999-04-30
PL167448B1 (pl) 1995-09-30
DE69116815D1 (de) 1996-03-14
IL114589A0 (en) 1995-11-27
JP3130097B2 (ja) 2001-01-31
IL114589A (en) 1999-12-22
DE69116815T2 (de) 1996-10-17
US5770579A (en) 1998-06-23
US5561118A (en) 1996-10-01
ATE133683T1 (de) 1996-02-15

Similar Documents

Publication Publication Date Title
FI915469A0 (fi) Foerfarande foer framstaellning av nya erytromycinderivat.
DK0642516T3 (da) Makrocykliske immunmodulatorer
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
DE69321875T2 (de) Benzimidezolderivate mit antidiabetischer und Anti-Plättchenklumpungswirkung
DK0447324T3 (da) 2,4-pyrimidindionderivater og lægemidler indeholdende disse
DE69310391D1 (de) Neue Naphthalin-Amide und Sulfonamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
YU86792A (sh) Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora
ATE17350T1 (de) Salicylsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung.
NO951444L (no) Gestagent aktive 19,11-broede 4-oestrener
DE69412980D1 (de) Eburnan-Derivate, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
ES2091570T3 (es) Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ZA934110B (en) Diacylglycerol nicotinates, process fot their preparation and the pharmaceutical compositions which contain them
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
FI934303A0 (fi) Acylsulfonamido- och sulfonamidopyridin-2-karboxylsyraestrar och deraspyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOECHST MARION ROUSSEL

MA Patent expired